Quarterly Balance Sheet

Oncolys BioPharma Inc. - Filing #7712868

Concept As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2016-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2015-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
As at
2014-12-31
Quarterly balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
2,564,045,000 JPY
3,605,286,000 JPY
Other
34,000 JPY
1,673,000 JPY
Current assets
2,746,518,000 JPY
3,673,702,000 JPY
Non-current assets
Property, plant and equipment
JPY
46,160,000 JPY
Property, plant and equipment
Buildings
2,794,000 JPY
13,355,000 JPY
Accumulated depreciation
-2,794,000 JPY
-1,730,000 JPY
Buildings, net
JPY
11,625,000 JPY
Tools, furniture and fixtures
66,630,000 JPY
103,412,000 JPY
Accumulated depreciation
-66,630,000 JPY
-68,877,000 JPY
Tools, furniture and fixtures, net
JPY
34,535,000 JPY
Intangible assets
JPY
4,132,000 JPY
Intangible assets
Software
JPY
4,132,000 JPY
Investments and other assets
393,795,000 JPY
281,963,000 JPY
Investments and other assets
Investment securities
351,940,000 JPY
248,082,000 JPY
Shares of subsidiaries and associates
10,173,000 JPY
JPY
Investments in capital
100,000 JPY
100,000 JPY
Long-term prepaid expenses
1,582,000 JPY
1,940,000 JPY
Other
19,000 JPY
19,000 JPY
Non-current assets
393,795,000 JPY
332,257,000 JPY
Assets
3,140,313,000 JPY
4,005,959,000 JPY
Liabilities
Current liabilities
Short-term borrowings
63,202,000 JPY
93,320,000 JPY
Income taxes payable
24,634,000 JPY
10,483,000 JPY
Current liabilities
204,849,000 JPY
176,966,000 JPY
Non-current liabilities
Long-term borrowings
300,000,000 JPY
303,202,000 JPY
Non-current liabilities
318,080,000 JPY
327,522,000 JPY
Liabilities
522,929,000 JPY
504,489,000 JPY
Net assets
Shareholders' equity
Share capital
5,090,981,000 JPY
5,072,338,000 JPY
Capital surplus
5,083,481,000 JPY
5,064,838,000 JPY
Retained earnings
-7,569,313,000 JPY
-6,637,915,000 JPY
Shareholders' equity
2,605,149,000 JPY
3,499,260,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
-8,370,000 JPY
-5,370,000 JPY
Valuation and translation adjustments
-8,370,000 JPY
-5,370,000 JPY
Share acquisition rights
20,604,000 JPY
7,580,000 JPY
Net assets
2,605,149,000 JPY
-8,370,000 JPY
-7,569,313,000 JPY
5,090,981,000 JPY
2,617,383,000 JPY
-7,569,313,000 JPY
-8,370,000 JPY
5,083,481,000 JPY
20,604,000 JPY
5,083,481,000 JPY
5,072,338,000 JPY
-6,637,915,000 JPY
-5,370,000 JPY
7,580,000 JPY
5,064,838,000 JPY
5,064,838,000 JPY
3,499,260,000 JPY
3,501,470,000 JPY
-5,370,000 JPY
-6,637,915,000 JPY
4,300,000 JPY
5,064,778,000 JPY
5,064,778,000 JPY
4,356,431,000 JPY
10,753,000 JPY
-5,780,624,000 JPY
4,371,484,000 JPY
5,072,278,000 JPY
-5,780,624,000 JPY
10,753,000 JPY
Liabilities and net assets
3,140,313,000 JPY
4,005,959,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.